ConductScience.org, home

Paper37556044

Cebranopadol for the Treatment of Chronic Pain.

Edinoff AN and 10 others. Curr Pain Headache Rep, 2023. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Cebranopadol for the Treatment of Chronic Pain. Papers, record 37556044. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37556044

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cebranopadol for the Treatment of Chronic Pain.
PubMed
Journal
Curr Pain Headache Rep
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.14
iCite
Revised in PubMed
2026-10-31
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Edinoff ANAmber Nhttps://orcid.org/0000-0001-7436-6206
2Flanagan CJChelsi J
3Roberts LTLogan T
4Dies RMRoss M
5Kataria SSaurabh
6Jackson EDEric D
7DeWitt AJAudrey J
8Wenger DMDanielle M
9Cornett EMElyse M
10Kaye AMAdam M
11Kaye ADAlan D

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chronic PainMajor topic
Humans
Quality of Life
Morphine
Indoles
Analgesics, Opioid
Nociceptin Receptor
Randomized Controlled Trials as Topic
Clinical Trials, Phase II as Topic
Spiro Compounds

Source PubMed

Download CSV of topics

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126748087Common Brain Mechanisms of Chronic Pain and Addiction.Neuron2016https://conductscience.org/library/papers/26748087PubMed
219889986Brain gray matter decrease in chronic pain is the consequence and not the cause of pain.J Neurosci2009https://conductscience.org/library/papers/19889986PubMed
327324708Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies.BMJ Open2016https://conductscience.org/library/papers/27324708PubMed
425248647Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist.Br J Anaesth2015https://conductscience.org/library/papers/25248647PubMed
530983589Transition from acute to chronic pain after surgery.Lancet2019https://conductscience.org/library/papers/30983589PubMed
624762001Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.Br J Pharmacol2014https://conductscience.org/library/papers/24762001PubMed
715561393Opioids in chronic non-cancer pain: systematic review of efficacy and safety.Pain2004https://conductscience.org/library/papers/15561393PubMed
822607834The economic costs of pain in the United States.J Pain2012https://conductscience.org/library/papers/22607834PubMed
925575710Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.Lancet Neurol2015https://conductscience.org/library/papers/25575710PubMed
1026028573Estimates of pain prevalence and severity in adults: United States, 2012.J Pain2015https://conductscience.org/library/papers/26028573PubMed
1126529271Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel.Pain2016https://conductscience.org/library/papers/26529271PubMed
1236045694The Ramifications of Opioid Utilization and Outcomes of Alternative Pain Control Strategies for Total Knee Arthroplasties.Orthop Rev (Pavia)2022https://conductscience.org/library/papers/36045694PubMed
1330531478Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study.J Clin Psychopharmacol2019https://conductscience.org/library/papers/30531478PubMed
1429071457Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain.Inflammopharmacology2018https://conductscience.org/library/papers/29071457PubMed
1516774457Differential diagnosis: nociceptive and neuropathic pain.Am J Manag Care2006https://conductscience.org/library/papers/16774457PubMed
1624590861Chemotherapy-induced peripheral neurotoxicity: a critical analysis.CA Cancer J Clin2013https://conductscience.org/library/papers/24590861PubMed
1728919117
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet2017https://conductscience.org/library/papers/28919117PubMed
1810334273Pain: an overview.Lancet1999https://conductscience.org/library/papers/10334273PubMed
1936118983Opioids in Urology: How Well Are We Preventing Opioid Dependence and How Can We Do Better?Health Psychol Res2022https://conductscience.org/library/papers/36118983PubMed
2023794652Neuropathic pain in cancer.Br J Anaesth2013https://conductscience.org/library/papers/23794652PubMed

See all 62 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42420592Structural basis for dual targeting of μ-opioid and nociceptin/orphanin FQ receptors by Cebranopadol.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42420592PubMed
40033110GPCR drug discovery: new agents, targets and indications.Nat Rev Drug Discov2025https://conductscience.org/library/papers/40033110PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37556044

GET https://conductscience.org/api/papers/v1/37556044/references?page=2